Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-12-16
|
pubmed:abstractText |
The influence of various patient and disease-related parameters on survival (S) and disease-free survival (DFS) in 217 node positive primary breast cancer patients treated with surgery followed by adjuvant i.v. cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) was evaluated by univariate and multivariate analyses. Five year actuarial S and DFS were 73.3% and 54.8%, respectively. Univariate analysis revealed that patient age, number of involved axillary nodes and ER status had a significant impact on both S and DFS. PgR positive tumors had improved DFS but no S difference was observed. Menopausal status predicted S but not DFS. Primary tumor size and CMF-induced amenorrhea did not predict disease outcome. Multivariate analysis demonstrated that only degree of nodal involvement and PgR status had independent significant impact on prognosis. Both S and DFS are significantly influenced by the number of involved nodes, whereas improved DFS but not S was evident in patients with PgR positive tumors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1555-8
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:1444221-Adult,
pubmed-meshheading:1444221-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1444221-Breast Neoplasms,
pubmed-meshheading:1444221-Cisplatin,
pubmed-meshheading:1444221-Female,
pubmed-meshheading:1444221-Fluorouracil,
pubmed-meshheading:1444221-Follow-Up Studies,
pubmed-meshheading:1444221-Humans,
pubmed-meshheading:1444221-Lymphatic Metastasis,
pubmed-meshheading:1444221-Methotrexate,
pubmed-meshheading:1444221-Middle Aged,
pubmed-meshheading:1444221-Prognosis,
pubmed-meshheading:1444221-Receptors, Estrogen,
pubmed-meshheading:1444221-Receptors, Progesterone,
pubmed-meshheading:1444221-Survival Analysis,
pubmed-meshheading:1444221-Time Factors
|
pubmed:articleTitle |
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.
|
pubmed:affiliation |
Department of Medical Oncology, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
|
pubmed:publicationType |
Journal Article
|